WUXI APPTEC (603259.SH): Plans to subscribe to private equity fund shares.

On December 19, Gronhui reported that WUXI APPTEC (603259.SH) announced that its wholly-owned subsidiary WuXiPharmaTechHealthcareFundIL.P. (referred to as "WuXiFundI") plans to subscribe for shares in the fund SOFINNOVABIOVELOCITAIIS.L.P. (referred to as "SofinnovaBiovelocitaII" or "SBVII") as a limited partner, with a subscription amount of 10 million euros (according to the exchange rate announced by the China Forex Trading Center on December 19, 2024).

Gelonghui Finance39minutes ago

WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St23:39 ET

Zhongtai: The implementation of the tenth batch of centralized procurement is expected to accelerate the clearance of generic drugs. Commercial insurance is an important incremental logic in the pharmaceutical Sector.

It is recommended to keep a close eye on the progress and implementation of commercial insurance, as improvements in the payment sector are expected to bring about a significant market trend in the Pharmaceutical Sector, with opportunities for recovery and reversal in hospital pharmaceuticals, diagnostics, and Medical Devices.

Zhitong FinanceDec 16 01:45 ET

Express News | UBS Group AG's Long Position in H-Shares of WuXi AppTec Increases to 5.63% on Dec 9 From 4.99% - HKEX

ReutersDec 13 04:10 ET

WuXi AppTec Co. Announces Board of Directors Changes

TipRanksDec 12 05:39 ET

WUXI APPTEC (02359.HK) plans to nominate Leng Xuesong as an independent non-executive Director candidate.

On December 12, Gelonghui reported that WUXI APPTEC (02359.HK) announced that according to the relevant provisions of the "Administrative Measures for Independent Directors of Listed Companies", the term of office for independent directors of listed companies shall not exceed six years. Since independent non-executive director Feng Dai's term as independent director of the company will reach six years, he can no longer serve as the company's independent director. Accordingly, Feng Dai has notified the Board of Directors that he will resign from the position of independent non-executive director of the third Board of Directors and from the role of chairman or member of certain board committees. After reviewing the relevant recommendations and qualifications, the Board of Directors has proposed to nominate Leng Xuesong as the candidate for independent non-executive director of the third Board of Directors.

Gelonghui FinanceDec 12 05:32 ET